Plenge et al.,
Reviewed the case of the genetic "dark matter", unaccounted for inherited risk.
Discussed use of GRAIL to enrich for SNP's to genotype in validation studies for GWAS.
Discussed prediction based on GWAS data (Plenge to lead).
LJ discussed how to determine if there is a subgroup of patients for which a test provides incremental value.
No comments:
Post a Comment